Cyndi Shannon Weickert | |
|---|---|
| Born | |
| Alma mater | National Institute of Mental Health Icahn School of Medicine at Mount Sinai Keuka College |
| Scientific career | |
| Institutions | University of New South Wales |
Cyndi Shannon Weickert is an American psychiatrist. Her research investigates the molecular developmental neurobiology of schizophrenia.
Weickert is from Finger Lakes. [1] She studied biology and psychology at Keuka College in upstate New York. [2] She completed her doctorate in Biomedical Science at the Icahn School of Medicine at Mount Sinai. She moved to the National Institute of Mental Health as a postdoctoral scholar, where she was eventually promoted to Unit Chief of Molecules in the Neurobiology Unit. [3]
Weickert studies the neurobiological mechanisms that underpin psychiatric disease. She investigates the cellular and molecular-level changes that take place in the brains of people suffering from schizophrenia. In 2010, she moved to Neuroscience Research Australia, [4] where she leads the translational research team. [2] She was appointed to the Board of the Schizophrenia International Research Society in 2012. [4]
Weickert looks to understand the relationship between brain inflammation and psychiatric disorders, and uses this understanding to develop personalised treatment. [5] She has shown that people with schizophrenia who have more brain inflammation have more complex neuropathologies, including more cortical thinning and poorer cognition. [1]
Weickert has contributed extensively to the understanding of schizophrenia. She has uncovered the impact of neurodevelopment on schizophrenia, in particular the role of blunted neuroplasticity, and disturbances in the brain-derived neurotrophic factor and estrogen receptor. [3] Her work revealed that postnatal recruitment of cortical inhibitory neurons is abnormal in people with schizophrenia. [6]
Weickert was awarded the 2016 Biological Psychiatry Australia Isaac Schweitzer Award. [3] In 2021, she was awarded the Schizophrenia International Research Society Outstanding Translational Research Awardee. [2]
Weickert had a twin brother who was diagnosed with schizophrenia at the age of 17. [1] He struggled to find effective treatment, and died from a cardiometabolic disease related to the schizophrenia in his early forties.